Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, via F. Scaduto 6/c, 90144 Palermo, Italy.
Nutr Metab Cardiovasc Dis. 2013 May;23(5):451-8. doi: 10.1016/j.numecd.2011.10.009. Epub 2012 Mar 7.
Accumulated evidence supports the effectiveness of Mediterranean-type diets (MeDiet) in reducing mortality and preventing several chronic diseases. Widely used scores to assess adherence to MeDiet are based on specific sample characteristics; alternatively, they might be built according to absolute/normative cut-off points for the consumption of specific food groups (pre-defined servings/day or/week). The aim of this study was to compare sample-specific MeDiet adherence scores (MDS) versus absolute-normative scores (Mediterranean Diet Adherence Screener - MEDAS) on their association with macronutrient intake, total mortality and incidence of chronic diseases.
SUN (Seguimiento Universidad de Navarra) dynamic prospective cohort study (60.5% women; mean age 38.4 years).
In cross-sectional analyses (n=20,155) we evaluated macronutrient distribution according to MDS (based on 136-item FFQ), MEDAS (based on 13 questions), and variants of both. In prospective analyses (n=9109; mean follow-up: 6.2 years), we evaluated disease incidence or mortality. Adherence to MeDiet increased with age and, as expected, was associated with higher fiber intake, lower total fat intake but higher monounsaturated/saturated fat ratio, using all scores. Among subjects initially free of cancer, diabetes, and cardiovascular disease (CVD), adherence to MeDiet appraised with an absolute-normative score (MEDAS) similarly predicted macronutrient distribution and disease incidence or mortality (diabetes incidence, CVD or all-cause mortality), when compared to a sample-specific score based on 136-item FFQ (MDS).
Adherence to MeDiet was associated with a decreased incidence of a composite outcome including diabetes incidence, cardiovascular events incidence or all-cause mortality.
越来越多的证据支持地中海式饮食(MeDiet)在降低死亡率和预防多种慢性疾病方面的有效性。广泛用于评估对 MeDiet 依从性的评分是基于特定样本特征的;或者,它们可以根据特定食物组的消费的绝对/规范截止点来构建(每天/每周规定的份数)。本研究的目的是比较基于样本的 MeDiet 依从性评分(MDS)与基于绝对规范的评分(地中海饮食依从性筛查器-MEDAS)在与宏量营养素摄入、总死亡率和慢性疾病发生率的相关性。
SUN(纳瓦拉大学随访)动态前瞻性队列研究(60.5%女性;平均年龄 38.4 岁)。
在横断面分析(n=20,155)中,我们根据 MDS(基于 136 项 FFQ)、MEDAS(基于 13 个问题)以及两者的变体评估了宏量营养素的分布。在前瞻性分析(n=9109;平均随访:6.2 年)中,我们评估了疾病的发病率或死亡率。与 MeDiet 的依从性随着年龄的增长而增加,并且如预期的那样,与更高的纤维摄入量、更低的总脂肪摄入量但更高的单不饱和/饱和脂肪比例相关,所有评分均如此。在最初没有癌症、糖尿病和心血管疾病(CVD)的受试者中,与基于 136 项 FFQ 的样本特定评分(MDS)相比,使用基于绝对规范的评分(MEDAS)评估的对 MeDiet 的依从性同样预测了宏量营养素的分布和疾病的发病率或死亡率(糖尿病发病率、CVD 或全因死亡率)。
对 MeDiet 的依从性与包括糖尿病发病率、心血管事件发病率或全因死亡率在内的复合结局的发生率降低相关。